Literature DB >> 16042129

[Group B streptococcus colonization during pregnancy and prevention of early onset of disease].

Jose Sad Larcher1, Florencia Capellino, Roxana De Giusto, Claudia Travella, Fabian Gomez Balangione, Gustavo Kreiker, Hernan Prats Cardona, Abel Zarate, Mario Vilaro, Daniela Hernandez, Guillermo Ruiz Orrico.   

Abstract

Group B Streptococcus (GBS) is the most frequent cause of early onset of neonatal sepsis. Case-fatality rate is 6-20% for newborns. Neurological sequel occurs in 30% of survivors. In 1996, the Centers for Disease Control and Prevention (CDC), the American College of Obstetricians and Gynecologists, and the American Academy of Pediatrics recommended that obstetrics providers should adopt either a culture-based or a risk-based approach for the prevention of this disease. The aim of this prospective study was to determine the colonization rate of GBS in our population of pregnant women between July 1st 2001 and December 31st 2002, and to introduce a culture-based strategy to prevent early onset neonatal GBS disease. From a population of 1756 pregnant women, 1228 were screened with rectal and vaginal swabs (69.9%). Maternal colonization rate was 1.4% (17 patients). There was one case of early-onset neonatal sepsis consistent with GBS disease (0.6%) in a patient with negative cultures. From the colonized patients, only one presented risk factors. Because most of the colonized women did not present intrapartum risk factors, the results of this study suggest that the culture-based approach should be used for the prevention of early-onset GBS disease in our population. Cost-benefit studies are needed in our country to determine if this prevention strategy is able to be implemented in all the settings of Argentina.

Entities:  

Mesh:

Year:  2005        PMID: 16042129

Source DB:  PubMed          Journal:  Medicina (B Aires)        ISSN: 0025-7680            Impact factor:   0.653


  9 in total

1.  Phlegmonous gastritis in a 32-week pregnant woman managed by conservative surgical treatment and antibiotics.

Authors:  Séverine Hommel; Guillaume Savoye; Camille Lorenceau-Savale; Bruno Costaglioli; François Baron; Florence Le Pessot; Françoise Lemoine; Eric Lerebours
Journal:  Dig Dis Sci       Date:  2007-03-07       Impact factor: 3.199

2.  Phenotypic and genotypic characterization of Streptococcus agalactiae in pregnant women. First study in a province of Argentina.

Authors:  P Oviedo; E Pegels; M Laczeski; M Quiroga; M Vergara
Journal:  Braz J Microbiol       Date:  2013-05-17       Impact factor: 2.476

3.  Prevalence, serotypes and virulence genes of Streptococcus agalactiae isolated from pregnant women with 35-37 weeks of gestation.

Authors:  Fernando J Bobadilla; Marina G Novosak; Iliana J Cortese; Osvaldo D Delgado; Margarita E Laczeski
Journal:  BMC Infect Dis       Date:  2021-01-14       Impact factor: 3.090

4.  Genomic analysis of virulence factors and antimicrobial resistance of group B Streptococcus isolated from pregnant women in northeastern Mexico.

Authors:  Gerardo Del Carmen Palacios-Saucedo; Lydia Guadalupe Rivera-Morales; José Manuel Vázquez-Guillén; Amilcar Caballero-Trejo; Melissa Carolina Mellado-García; Aldo Sebastián Flores-Flores; José Alfredo González-Navarro; Celia Geovana Herrera-Rivera; Luis Ernesto Osuna-Rosales; Julio Antonio Hernández-González; Ricardo Vázquez-Juárez; Carolina Barrón-Enríquez; Ramón Valladares-Trujillo; Joaquín Dario Treviño-Baez; César Alejandro Alonso-Téllez; Luis Daniel Ramírez-Calvillo; Ricardo Martín Cerda-Flores; Rocío Ortiz-López; Miguel Ángel Rivera-Alvarado; Fortino Solórzano-Santos; Jorge Castro-Garza; Cristina Rodríguez-Padilla
Journal:  PLoS One       Date:  2022-03-16       Impact factor: 3.240

5.  Epidemiology and aetiology of maternal bacterial and viral infections in low- and middle-income countries.

Authors:  Prasad Palani Velu; Courtney A Gravett; Tom K Roberts; Thor A Wagner; Jian Shayne F Zhang; Craig E Rubens; Michael G Gravett; Harry Campbell; Igor Rudan
Journal:  J Glob Health       Date:  2011-12       Impact factor: 4.413

6.  Antibiotic susceptibility patterns and prevalence of group B Streptococcus isolated from pregnant women in Misiones, Argentina.

Authors:  M Quiroga; E Pegels; P Oviedo; E Pereyra; M Vergara
Journal:  Braz J Microbiol       Date:  2008-06-01       Impact factor: 2.476

7.  Emerging trends in invasive and noninvasive isolates of Streptococcus agalactiae in a Latin American hospital: a 17-year study.

Authors:  Maria del Pilar Crespo-Ortiz; Claudia Rocio Castañeda-Ramirez; Monica Recalde-Bolaños; Juan Diego Vélez-Londoño
Journal:  BMC Infect Dis       Date:  2014-08-03       Impact factor: 3.090

Review 8.  Infant Group B Streptococcal Disease Incidence and Serotypes Worldwide: Systematic Review and Meta-analyses.

Authors:  Lola Madrid; Anna C Seale; Maya Kohli-Lynch; Karen M Edmond; Joy E Lawn; Paul T Heath; Shabir A Madhi; Carol J Baker; Linda Bartlett; Clare Cutland; Michael G Gravett; Margaret Ip; Kirsty Le Doare; Craig E Rubens; Samir K Saha; Ajoke Sobanjo-Ter Meulen; Johan Vekemans; Stephanie Schrag
Journal:  Clin Infect Dis       Date:  2017-11-06       Impact factor: 20.999

9.  Vagino-rectal colonization prevalence by Streptococcus agalactiae and its susceptibility profile in pregnant women attending a third-level hospital

Authors:  César Hernán Campo; María Fernanda Martínez; Juan Carlos Otero; Giovanna Rincón
Journal:  Biomedica       Date:  2019-12-01       Impact factor: 0.935

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.